Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): A six-month follow-up study

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 83-88

  Jaeger, Susanne ^a   Pfiffner, Carmen ^a   Weiser, Prisca ^a   Kilian, Reinhold ^a   Becker, Thomas ^a   Längle, Gerhard ^b,c   Eschweiler, Gerhard Wilhelm ^b   Croissant, Daniela ^c   Schepp, Wiltrud ^d   Steinert, Tilman ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Klinik für Psychiatrie und Psychotherapie Zwiefalten   (Germany)

^d Bezirksklinikum Regensburg   (Germany)

Author keywords

Antipsychotics; Compliance; LCA; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INTROSPECTION; LATENT CLASS ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT CODING; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PATIENT SATISFACTION; PREDICTIVE VALIDITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; RATING SCALE; RELIABILITY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STATISTICAL ANALYSIS; TREATMENT INDICATION;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; PATIENT SATISFACTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84872388970     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.03.033     Document Type: Article

References (30)

1. Ahn J., McCombs J.S., Jung C., Croudace T.J., McDonnell D., Ascher-Svanum H., Edgell E.T., Shi L. Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) Program. Value in Health 2008, 11:48-56.
2. Diagnostic and Statistical Manual of Mental Disorders: DSM IV 2000, American Psychiatric Association, American Psychiatric Association, Washington, DC, (text revision). 4th ed.
3. Barbui C., Kikkert M., Mazzi M.A., Becker T., Bindman J., Schene A., Nosè M., Helm H., Thornicroft G., Tansella M. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence. Psychopathology 2009, 42:311-317.
4. Beck E.M., Cavelti M., Wirtz M., Kossowsky J., Vauth R. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach. Psychiatry Research 2011, 187:55-61.
5. S3 Praxisleitlinien in Psychiatrie und Psychotherapie, Bd.1, Behandlungsleitlinie Schizophrenie 2006, DGPPN [Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde], Springer, Berlin.
6. Fenton W.S., Blyler C.R., Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 1997, 23:637-651.
7. Fialko L., Garety P.A., Kuipers E., Dunn G., Bebbington P.E., Fowler D., Freeman D. A large-scale validation study of the medication adherence rating scale (MARS). Schizophrenia Research 2008, 100:53-59.
8. Freudenreich O., Tranulis C. A prototype approach toward antipsychotic medication adherence in schizophrenia. Harvard Review of Psychiatry 2009, 17:35-40.
9. Giles J. Social science lines up its biggest challenges. 'Top ten' crucial questions set research priorities for the field. Nature 2011, 470:18-19.
10. Hogan T.P., Awad A.G., Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine 1983, 13:177-183.
11. Hui C.L.M., Chen E.Y.H., Kan C.S., Yip K.C., Law C.W., Chiu C.P.Y. Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong. The Keio Journal of Medicine 2006, 55:9-14.
12. Jaeger S., Gebhardt R.-P., Pfiffner C., Bayer W., Weiser P., Wiesner H., Steinert T. Akzeptanz und Umsetzung von Empfehlungen zur Rückfallverhütung - Entwicklung der Compliance Selbst-Rating Instrumente CSRI-E und CSRI-K. Psychische Erkrankungen in der Lebensspanne - Abstractband zum DGPPN Kongress 2009 2009, 93. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde, Berlin. F. Schneider, M. Grözinger (Eds.).
13. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
14. Kikkert M.J., Koeter M.W., Dekker J.J., Burti L., Robson D., Puschner B., Schene A.H. The predictive validity of subjective adherence measures in patients with schizophrenia. International Journal of Methods in Psychiatric Research 2011, 20:73-81.
15. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 2002, 63:892-909.
16. Laengle G., Bayer W., Eschweiler G., Jaeger S., Pfiffner C., Weiser P., Croissant D., Kilian R., Becker T., Steinert T. Effects of longterm treatment with atypical neuroleptics for patients with schizophrenia (ELAN): medication use, adherence, functional impairment, quality of life. European Psychiatry 2010, 25(Supplement 1):1614.
17. Lazarsfeld P.F. The logical and mathematical foundations of latent structure analysis. Measurement and Prediction 1950, 362-412. Princeton University Press, Princeton, NJ. S.A. Stouffer, L. Guttman, E.A. Suchman, P.F. Lazarsfeld, S.A. Star, J.A. Clausen (Eds.).
18. McCutcheon A. Latent Class Analysis 1987, Sage, Newbury Park, CA.
19. Misdrahi D., Verdoux H., Llorca P.M., Baylé F.J. Therapeutic adherence and schizophrenia: the interest of the validation of the French translation of Medication Adherence Rating Scale (MARS) [Letter]. Encephale 2004, 30:409-410.
20. Mitchell A.J., Selmes T. Why don't patients take their medicine? Reasons and solutions in psychiatry. Advances in Psychiatric Treatment 2007, 13:336-346.
21. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 1986, 24:67-74.
22. NICE [National Institute for Health and Clinical Excellence], 2009. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (update). URL: (10/16/2011). http://guidance.nice.org.uk/CG82.
23. Rosa A.R., Marco M., Fachel J.M., Kapczinski F., Stein A.T., Barros H.M. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:217-224.
24. Rummel-Kluge C., Pitschel-Walz G., Kissling W. A fast, implementable psychoeducation program for schizophrenia. Psychiatric Services 2007, 58:1226.
25. Schnell T., Neisius K., Daumann J., Gouzoulis-Mayfrank E. Prävalenz der Komorbidität Psychose und Sucht - Untersuchungsergebnisse aus einer deutschen Großstadt. [Prevalence of psychosis/substance use comorbidity. Clinical-epidemiological findings from different treatment-settings in a large German city]. Nervenarzt 2010, 81:32-38.
26. Thompson K., Kulkarni J., Sergejew A.A. Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophrenia Research 2000, 42:241-247.
27. Velligan D.I., Lam Y.W.F., Glahn D.C., Barrett J.A., Maples N.J., Ereshefsky L., Miller A.L. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophrenia Bulletin 2006, 32:724-742.
28. Velligan D.I., Weiden P.J., Sajatovic M., Scott J., Carpenter D., Ross R., Docherty J.P. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines. Journal of Psychiatric Practice 2010, 16:34-45.
29. Viguera A.C., Baldessarini R.J., Hegarty J.D., van Kammen D.P., Tohen M. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry 1997, 54:49-55.
30. Wolzniak A., Szafranski T. Polish version of medication adherence rating scale (MARS). Pharmacopsychiatry 2003, 36:274.